PRESS RELEASE published on 10/24/2024 at 08:00, 1 year 7 months ago Franchissement d’une nouvelle étape décisive dans la réalisation de la restructuration financière : Arrêté du plan de sauvegarde accélérée d’Atos par le Tribunal de commerce spécialisé de Nanterre Atos franchit une étape décisive avec l'arrêt du plan de sauvegarde accélérée par le Tribunal de commerce de Nanterre, dans le cadre de sa restructuration financière Restructuration Financière Sauvegarde Accélérée Tribunal De Commerce Atos Nanterre
PRESS RELEASE published on 10/24/2024 at 07:46, 1 year 7 months ago SAVENCIA : Activité à fin septembre 2024 Le chiffre d'affaires du Groupe Savencia Fromage & Dairy progresse de 1,3% à fin septembre 2024, porté par la croissance organique des Autres Produits Laitiers et un effet de structure positif Chiffre D'affaires Croissance Organique Engagements RSE Savencia Fromage & Dairy Effet De Structure
PRESS RELEASE published on 10/24/2024 at 07:46, 1 year 7 months ago SAVENCIA: Activity at the end of September 2024 Savencia Fromage & Dairy Group reports 1.3% sales growth in September 2024 driven by Other Dairy Products and favorable structural effects. Commitment to quality and sustainability initiatives highlighted Sustainability Sales Growth Commitments Savencia Dairy Group
PRESS RELEASE published on 10/24/2024 at 07:46, 1 year 7 months ago Ipsos : Ralentissement de l’activité dans un climat des affaires plus difficile Ipsos annonce un ralentissement de l’activité avec 591M € de CA au T3 2024, contexte macroéco incertain. Poursuite des investissements dans l'IA et acquisitions Croissance Investissements IA Activité Ipsos
PRESS RELEASE published on 10/24/2024 at 07:46, 1 year 7 months ago Ipsos: Slowdown in activity in a more difficult business climate Ipsos achieved 0.5% revenue growth in Q3 2024 amid challenging business climate. Mixed performance across markets influenced by macroeconomic conditions. CEO optimistic about future tech investments and maintaining 13% operating margin target Revenue Growth Operating Margin Ipsos Business Climate Macroeconomics
PRESS RELEASE published on 10/24/2024 at 07:36, 1 year 7 months ago ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA ONWARD® Medical raises EUR 50 million with strategic investment from Ottobock SE & Co. KGaA, extending cash runway. Ottobock acquires c.10% share capital, initiating collaboration for spinal cord injury therapies Investment EUR 50 Million ONWARD Medical Ottobock SE & Co. KGaA Spinal Cord Injury Therapies
REGULATED PRESS RELEASE published on 10/24/2024 at 07:35, 1 year 7 months ago Activité du troisième trimestre et des neuf premiers mois 2024 & Finalisation du regroupement d’actions Solocal annonce les résultats du troisième trimestre 2024, finalisation du regroupement d'actions et perspectives 2024. Chiffre d'affaires en baisse, marge d'EBITDA maintenue à 15% Chiffre D'affaires Solocal Résultats Marge D'EBITDA Regroupement D'actions
REGULATED PRESS RELEASE published on 10/24/2024 at 07:35, 1 year 7 months ago Q3 and 9M 2024 activity & Completion of the reverse share split Solocal Group reports Q3 and 9M 2024 activity results including completion of reverse share split. Confirmation of 2024 outlook with secured revenue of €305 million and Group's revenue could reach c. €340 million. Completion details of reverse share split outlined Solocal Group Q3 2024 Reverse Share Split 9M 2024 Secured Revenue
PRESS RELEASE published on 10/24/2024 at 07:34, 1 year 7 months ago Activité du troisième trimestre et des neuf premiers mois 2024 & Finalisation du regroupement d’actions Solocal Group annonce une activité en baisse pour le troisième trimestre et les neuf premiers mois 2024, avec un chiffre d'affaires consolidé prévu à 340 millions € en 2024. Finalisation du regroupement d'actions avec un nouveau nombre d'actions en circulation de 33 316 837. Perspectives 2024 confirmées Chiffre D'affaires Solocal Group Perspectives 2024 Regroupement D'actions Activité
PRESS RELEASE published on 10/24/2024 at 07:30, 1 year 7 months ago Rentschler Biopharma announces largest single investment at its headquarters in Germany Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
Published on 05/28/2026 at 01:15, 4 hours 18 minutes ago JM Capital II Corp. Announces Departure of President, Chief Financial Officer and Chief Financial Officer Jay Freeman
Published on 05/28/2026 at 00:55, 4 hours 38 minutes ago First Helium Closes Oversubscribed $2.6 Million Placement
Published on 05/27/2026 at 23:42, 5 hours 51 minutes ago New Horizon Aircraft Ltd. Announces Closing of $25 Million Offering of Common Shares
Published on 05/27/2026 at 23:05, 6 hours 28 minutes ago Vox Royalty Announces Annual and Special Meeting Results
Published on 05/27/2026 at 23:05, 6 hours 28 minutes ago Avino Reports Voting Results of Its 2026 Annual General Meeting
Published on 05/27/2026 at 23:29, 6 hours 3 minutes ago Market entry in Brazil: DEUTZ expands its energy business in Latin America
Published on 05/27/2026 at 23:09, 6 hours 23 minutes ago EQS-Adhoc: DEUTZ AG acquires Brazilian generator manufacturer Maxi Trust Power Ltda.
Published on 05/27/2026 at 20:52, 8 hours 40 minutes ago EQS-Adhoc: REPLOID Group AG: Procedural deficiencies related to the appointment of auditors in prior periods require remediation. Publication of the 2025 Annual Statements delayed.
Published on 05/27/2026 at 20:32, 9 hours ago Sirma Group Holding AD reports strong profitability growth in Q1 2026
Published on 05/27/2026 at 19:55, 9 hours 37 minutes ago IGEL Brings Now & Next Workspace & Endpoint Security Summits to Five European Cities
Published on 05/27/2026 at 23:00, 6 hours 33 minutes ago BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Published on 05/27/2026 at 23:00, 6 hours 33 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 9 hours 4 minutes ago Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 11 hours 48 minutes ago Imerys-05-2026-communique-capital-droits-de-vote-au-30-avril-2026